GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » Gross-Profit-to-Asset %

Mezzion Pharma Co (XKRX:140410) Gross-Profit-to-Asset % : 2.17% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Mezzion Pharma Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ₩1,948 Mil. Mezzion Pharma Co's average Total Assets over the quarter that ended in Mar. 2024 was ₩89,934 Mil. Therefore, Mezzion Pharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 2.17%.


Mezzion Pharma Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Mezzion Pharma Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mezzion Pharma Co Gross-Profit-to-Asset % Chart

Mezzion Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.33 11.06 4.64 -0.45 5.31

Mezzion Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.41 5.49 5.48 4.33 2.17

Competitive Comparison of Mezzion Pharma Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - General subindustry, Mezzion Pharma Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mezzion Pharma Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mezzion Pharma Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Mezzion Pharma Co's Gross-Profit-to-Asset % falls into.



Mezzion Pharma Co Gross-Profit-to-Asset % Calculation

Mezzion Pharma Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=3884.44/( (54021.841+92149.354)/ 2 )
=3884.44/73085.5975
=5.31 %

Mezzion Pharma Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1947.584/( (92149.354+87719.289)/ 2 )
=1947.584/89934.3215
=2.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Mezzion Pharma Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mezzion Pharma Co (XKRX:140410) Business Description

Traded in Other Exchanges
N/A
Address
C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co (XKRX:140410) Headlines

No Headlines